Thomas Klenzner

In addition, cochlear organized a lunch Symposium (room Zagreb) on May 17th from 12:00 to 13:00. Implantable titled, stimulating, innovative!”awaits an update on products and therapies from cochlear. Professor Thomas Lenarz (Hannover) is dedicated to the results of CI implantation in an extension of the indication area with hybrid and SRA electrodes in a lecture. Discuss in the subsequent Round-Table discussion next to the speakers also PD Dr. Susan Arndt (Freiburg), Dr. Diana ABI Rached Harbeck (eat), PD Dr.

Thomas Klenzner (Dusseldorf), Professor Heidi Sandals (Berlin) and Professor Mark Praetorius (Heidelberg) current and future CI indication extensions and the associated surgical requirements. CBC, Australia has many thoughts on the issue. The discussion will be moderated by Professor Timo Stover (Frankfurt). “Charitable action meeting you the auditory nerve!” in favour of impaired children as in the previous year cochlear uses his Congress appearance for a charitable purpose. “The charity action meeting you the auditory nerve!” can do something good for all visitors. For each participant of the action, cochlear donates up to five euros in favour of the national school for the deaf and hard of hearing in Neuwied. The hearing impaired school wants to use the proceeds for the purchase of a climbing wall.

These should not only allow students to train body awareness and balance, but also self-confidence. The annual meeting of the German society of Otolaryngology, head and neck surgery is a valuable platform for exciting encounters and the lively exchange with physicians and audiologists for us for a long time”, so Frederec LAU. In 2012, we want to introduce a variety of latest trends in implantable hearing solutions to trade visitors. And we hope again on many good talks and interesting impulses. Without the trust and partnership-based dialog with the specialists from clinics and CI centres the development and the application of trend-setting hearing implant conceivable not.” Editorial Note: the company cochlear is global market leader in the development and manufacture of cochlear implants (CI). The breakthrough technology of this CI systems allows to listen to children and adults with profound and adjacent to deafness hearing loss. In addition develops and markets the company more implantable hearing solutions for different types of hearing loss. For over 30 years, continues the cochlear that research work of Australian Medicine Professor Graeme Clark, the inventor of the multiple-channel cochlear implant, and marketed CI systems in more than 100 countries. Cochlear hearing solutions have brought back closer to their families and friends until today more than 250,000 people. In cochlear guarantees all users of its products a lifetime partnership with updates and developments of the technologies. The industry’s Cochlear secures its leading position in the science of hearing largest investments in research and development and continuous collaboration with leading researchers and experts. The company employs currently over 2,500 people. The German branch of cochlear is Hanover. For more information see. The cochlear implant is inserted under the skin of the patients, ranging in the inner ear. It transforms spoken words and other acoustic signals into electrical impulses. The auditory nerve is stimulated by these impulses, which is located in the cochlea, the so called cochlear. Each CI also includes a sound processor with emitter, which is worn like a hearing aid behind the ear. The CI will open access to the world of hearing and the words spoken born deaf children, as well as highly hearing impaired children and adults.